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London, 20th October 2016 
 
“FKBP51 in health and disease” 
 
 
 9:15-9:30: Arrival, introduction, coffee/tea 
 
 
 9:30-11:00: The mode of action of FKBP51 inhibitors and FKBP51 in depression 
 
Felix Hausch, Chemical Genomics group, Dept. Translational Research in Psychiatry, MPI: 
"The many faces of FKBP51? - Studies on the mode of action of FKBP51 inhibitors" 
 
Theo Rein, Molecular Pathways of Depression, Dept. Translational Research in Psychiatry, 
MPI: 
“Mechanism and function of the stress protein FKBP51 in pathways relevant for depression 
and antidepressant pharmacology” 
 
 11:15-12:45: FKBP51 in stress and the glucocorticoid system 
 
Mathias Schmidt, Neurobiology of Stress Resilience, Dept. Stress Neurobiology and 
Neurogenetics, MPI: 
“The role of FKBP51 in regulating stress system activity and behaviour” 
 
Becky Conway-Campbell, School of Clinical Sciences, Professor Stafford Lightman’s 
group, University of Bristol: 
“Glucocorticoid regulation of the rat hippocampal transcriptome and function' 
 
 12:45-14:00: Sandwich lunch / discussion on potential collaborations / joint grant 
applications 
 
 14:00-15:30: FKBP51 in cancer and pain 
 
Fiammetta Romano / Simona Romano, Department of Molecular Medicine and Medical 
Biotechnology, Federico II University, Naples: 
“FKBP51 isoforms in cancer” 
 
Maria Maiarù / Sandrine Géranton, Department of Cell and Developmental Biology, UCL, 
London: 
“The regulation of pain states by FKBP51” 
 
 
 15:30: End of meeting; departure for airports or tour of the London labs if wanted! 
 
